Observational study to assess the characteristics and outcomes of patients with refractory/relapsed diffuse large B cell lymphoma who received R-GemOx as second line or above treatment (MK-2140-012)

Data sources

• Data source(s), other:
  Electronic medical records; hospital information systems; laboratory information management systems (LIS); radiology information systems (RIS); picture archiving and communication systems (PACS); China Center for Disease Control and Prevention (China CDC); Other medical records
• Data sources (types):
  Non-interventional study

Use of a Common Data Model (CDM)

• CDM mapping:
  Yes

CDM Mappings

• CDM name:
  CDISC SDTM
• CDM website:
  https://www.cdisc.org/standards/foundational/sdtm

Data quality specifications

• Check conformance:
  Yes
• Check completeness:
  Yes
• Check stability:
  Yes
• Check logical consistency:
  Yes

Data characterisation

• Data characterisation conducted:
  Yes